Recombinant Human Interleukin-11
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Human Interleukin-11, covering 2013-02-08 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11 [Phase 3]